Wegovy to Mounjaro Switch UK - Cheapest Price £124.99

Clinically Proven UK Registered Pharmacy

Cheapest Wegovy to Mounjaro Switch - UK Price £124.99

Switch from Wegovy to Mounjaro at the cheapest UK price from £124.99 with £20 off using code Weightlossnew.

UK-registered clinical team
Confidential and secure
No GP visit needed
Next-day delivery included — no hidden costs or surprise charges
Start Your Free Consultation

Takes less than 2 minutes to complete 100% online

Weightlossnew £20 off for new customers

Treatment from £124.99

Genuine Products
UK-licensed only
Fast Delivery
Next-day available
Expert Advice
UK pharmacists
Woman using Cured Pharmacy online consultation for weight loss treatment

Check your BMI

Height 175 cm
Weight 82 kg

Your BMI

26.8
Start Free Consultation

Free · BMI thresholds shown are illustrative. Final eligibility is confirmed by a UK prescriber during your free consultation.

LIVE PRICING

Our Pricing

Pricing Disclaimer: Prices on some pages may not be up to date — the live pricing table below and pricing shown during consultation are official current prices and take precedence over any other figures on the site.

Mounjaro (Tirzepatide)
Weeks 1–4

2.5mg

1 pen • 4 Weeks

£145 £124.99

£31.25 / Per Week

Your starting dose – designed to help your body adjust gently to treatment

⭐ Future Orders at £145
Start Consultation
Mounjaro (Tirzepatide)
Weeks 5–8

5mg

1 pen • 4 Weeks

£179 £159.00

£39.75 / Per Week

First step up – builds on your progress as your body adapts to treatment

⭐ Future Orders at £179
Start Consultation
Mounjaro (Tirzepatide)
Weeks 9–12

7.5mg

1 pen • 4 Weeks

£220 £200.00

£50.00 / Per Week

Mid-range dose – for continued progression and enhanced results

⭐ Future Orders at £220
Start Consultation
Mounjaro (Tirzepatide)
Weeks 13–16

10mg

1 pen • 4 Weeks

£245 £225.00

£56.25 / Per Week

Higher strength dose – supports significant weight loss progress

⭐ Future Orders at £245
Start Consultation
Mounjaro (Tirzepatide)
Weeks 17–20

12.5mg

1 pen • 4 Weeks

£270 £250.00

£62.50 / Per Week

Advanced dose – for patients requiring stronger therapeutic effect

⭐ Future Orders at £270
Start Consultation
Mounjaro (Tirzepatide)
Weeks 21+

15mg

1 pen • 4 Weeks

£287 £267.00

£66.75 / Per Week

Maximum dose – the highest available strength for optimal results

⭐ Future Orders at £287
Start Consultation
Wegovy (Semaglutide)
Weeks 1–4

0.25mg

1 pen • 4 Weeks

£89 £69.00

£17.25 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £89
Start Consultation
Wegovy (Semaglutide)
Weeks 5–8

0.5mg

1 pen • 4 Weeks

£109 £89.00

£22.25 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £109
Start Consultation
Wegovy (Semaglutide)
Weeks 9–12

1mg

1 pen • 4 Weeks

£119 £99.00

£24.75 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £119
Start Consultation
Wegovy (Semaglutide)
Weeks 13–16

1.7mg

1 pen • 4 Weeks

£169 £149.00

£37.25 / Per Week

Higher strength – supports accelerated weight loss progress

⭐ Future Orders at £169
Start Consultation
Wegovy (Semaglutide)
Weeks 17+

2.4mg

1 pen • 4 Weeks

£199 £179.00

£44.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199
Start Consultation
Wegovy (Oral Pill)
Weeks 1–4

1.5mg

1 pen • 4 Weeks

£83.00 £63.00

£20.75 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £83.00
Start Consultation
Wegovy (Oral Pill)
Weeks 5–8

4mg

1 pen • 4 Weeks

£110.00 £90.00

£27.50 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £110.00
Start Consultation
Wegovy (Oral Pill)
Weeks 9–12

9mg

1 pen • 4 Weeks

£140.00 £120.00

£35.00 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £140.00
Start Consultation
Wegovy (Oral Pill)
Weeks 13+

25mg

1 pen • 4 Weeks

£199.00 £179.00

£49.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199.00
Start Consultation

How to Switch From Wegovy to Mounjaro: Clinical Guidance for UK Patients

Many patients considering a Wegovy to Mounjaro switch are looking for improved weight loss outcomes or better tolerability profiles. As a UK-registered pharmacy with thousands of weight management patients under care, we've supported numerous successful transitions between these GLP-1 medications. This guide provides the clinical framework our prescribers use when facilitating switches from semaglutide to tirzepatide therapy.

Why Patients Consider a Wegovy to Mounjaro Switch

The decision to switch from Wegovy to Mounjaro typically stems from three clinical scenarios our prescribers encounter regularly. First, patients who have plateaued on Wegovy 1.7mg or higher doses may seek the dual-agonist mechanism of tirzepatide for additional weight loss potential. The SURPASS-2 trial demonstrated that tirzepatide 15mg produced superior weight reduction compared to semaglutide 1mg, with average losses of 12.4kg versus 6.2kg respectively over 40 weeks[1].

Second, some patients experience persistent gastrointestinal side effects on Wegovy that may improve with Mounjaro's different receptor activity profile. Whilst both medications affect GLP-1 receptors, tirzepatide's additional GIP agonism can alter the side effect profile in ways that benefit certain individuals[2]. Third, cost considerations drive switches, particularly when Mounjaro pricing becomes more competitive than Wegovy for equivalent therapeutic outcomes.

Our clinical team evaluates each switch request individually, considering your current Wegovy dose, weight loss trajectory, side effect history, and treatment goals. Not every patient requires a switch - those responding well to Wegovy with minimal side effects often continue their current therapy. However, for patients meeting specific clinical criteria, transitioning to Mounjaro can offer renewed progress towards weight management targets.

Clinical Protocol for Wegovy to Mounjaro Switch Timing

The pharmacokinetic profile of semaglutide requires careful consideration when planning your Wegovy to Mounjaro switch timeline. Semaglutide has a half-life of approximately 7 days, meaning it takes roughly 4-5 weeks to fully clear from your system[3]. However, our prescribers don't typically recommend waiting for complete clearance before initiating Mounjaro.

The standard protocol we follow involves administering your first Mounjaro dose one week after your final Wegovy injection. This timing balances two priorities: avoiding a gap in GLP-1 receptor stimulation that could trigger rebound appetite, whilst minimising overlapping drug exposure that might intensify gastrointestinal effects. If you're currently on Wegovy 1.7mg, you'll typically start Mounjaro at the 2.5mg initiation dose, regardless of your Wegovy dose level.

Some patients worry about 'starting over' with the lower Mounjaro dose, but this graduated approach significantly reduces side effect risk during the transition period. The tirzepatide dose escalation schedule (2.5mg, 5mg, 7.5mg, 10mg, 12.5mg, 15mg) allows your body to adapt to the dual-agonist mechanism whilst maintaining therapeutic effect from residual semaglutide levels during the first few weeks.

Managing the Transition Week

The week between your last Wegovy dose and first Mounjaro injection represents a critical transition period. Our pharmacists recommend maintaining consistent meal timing and composition during this week to avoid appetite fluctuations. Stay well-hydrated and monitor for any return of hunger signals, which typically remain suppressed due to residual semaglutide activity. If you experience concerning symptoms during this transition week, our clinical team is available for guidance before you administer your first Mounjaro dose.

Expected Outcomes When Switching From Wegovy to Mounjaro

Patients completing a Wegovy to Mounjaro switch often ask what weight loss outcomes they should anticipate. Clinical trial data provides useful benchmarks, though individual results vary considerably. In the SURPASS-2 head-to-head trial, participants switching to tirzepatide after previous GLP-1 RA therapy achieved meaningful additional weight reduction, though not as dramatic as treatment-naïve patients[1].

During your first 12 weeks on Mounjaro following the switch, expect a continuation of gradual weight loss rather than the accelerated losses sometimes seen in treatment-naïve patients. The SURPASS trials showed that tirzepatide's weight loss effect accumulates over 40-72 weeks, with many patients achieving their maximum benefit between months 9-12[4]. Your previous Wegovy therapy has already addressed some of the initial rapid weight loss phase, so post-switch expectations should focus on steady progress towards your goal weight.

Side effect profiles during the Wegovy to Mounjaro switch vary by individual. Some patients report reduced nausea compared to their Wegovy experience, whilst others notice similar or slightly increased gastrointestinal effects during the first 4-6 weeks. These typically resolve as you adapt to tirzepatide's mechanism. Our prescribers recommend the same side effect management strategies used during initial Wegovy titration: smaller, more frequent meals, adequate hydration, and avoiding high-fat foods during the adaptation period.

Treatment Active Ingredient Mechanism Starting Dose Price From
Wegovy Semaglutide GLP-1 agonist 0.25mg weekly £169.00
Mounjaro Tirzepatide GLP-1/GIP dual agonist 2.5mg weekly £145.00
Wegovy Oral Semaglutide GLP-1 agonist 3mg daily £83.00
Saxenda Liraglutide GLP-1 agonist 0.6mg daily £68.00

Wegovy to Mounjaro Switch Prescription Process at Cured Pharmacy

Obtaining your Wegovy to Mounjaro switch prescription through Cured Pharmacy follows a streamlined clinical pathway designed by our superintendent pharmacist, Tarun Kumar (GPhC 2233073). The process begins with a comprehensive online assessment that captures your complete Wegovy treatment history, including doses used, duration of therapy, weight loss achieved, and any side effects experienced. This information allows our prescribers to make informed decisions about your suitability for switching.

Our UK-registered prescribers review every switch request individually, considering clinical guidelines from NICE and MHRA licensing conditions for tirzepatide. The assessment typically takes under 3 minutes to complete but provides our clinical team with the detailed information needed for safe prescribing. We'll ask about your current weight, BMI, any weight-related comorbidities, other medications you're taking, and your weight loss goals. This thorough approach ensures your Wegovy to Mounjaro switch is clinically appropriate and likely to benefit your overall health outcomes.

Once approved, your Mounjaro prescription is dispensed from our GPhC-registered pharmacy (9012511) with next-day delivery available across the UK. All medications are UK-licensed tirzepatide in the original manufacturer packaging. Your first order qualifies for £20 off using code Weightlossnew, bringing the price to £124.99. We provide complete dosing instructions, injection technique guidance, and access to our pharmacist support team throughout your treatment journey.

Ongoing Clinical Monitoring After Your Switch

Following your Wegovy to Mounjaro switch, our clinical team recommends monthly weight tracking and quarterly clinical reviews to assess treatment response. These check-ins allow our prescribers to optimise your dose escalation schedule and address any emerging concerns. We monitor for adequate weight loss (typically defined as 5% body weight reduction within 12 weeks of reaching therapeutic doses), side effect tolerability, and any changes in comorbid conditions like type 2 diabetes or hypertension that often improve with significant weight loss.

Cost Comparison: Wegovy to Mounjaro Switch Financial Considerations

The financial aspect of a Wegovy to Mounjaro switch represents a significant consideration for most patients, particularly those funding treatment privately. At Cured Pharmacy, Mounjaro starts from £124.99, with your first order eligible for £20 off using code Weightlossnew. This pricing structure makes the switch financially accessible whilst maintaining the quality standards expected from a UK-registered pharmacy.

When evaluating the cost-effectiveness of your Wegovy to Mounjaro switch, consider the complete treatment pathway rather than single-pen pricing. Tirzepatide's superior weight loss outcomes in clinical trials may allow some patients to reach their goal weight faster, potentially reducing the total treatment duration required[1]. However, individual responses vary, and our prescribers emphasise that medication choice should be driven primarily by clinical factors rather than cost alone.

Cured Pharmacy maintains transparent upfront pricing with no hidden consultation fees or subscription requirements. The price you see includes the medication, clinical assessment by a UK prescriber, and dispensing by our registered pharmacy team. We guarantee the lowest prices in the UK market, and our price-match commitment ensures you're receiving competitive value for your Wegovy to Mounjaro switch prescription.

Safety Considerations for Your Wegovy to Mounjaro Switch

Safety remains paramount when facilitating any medication switch, and the Wegovy to Mounjaro transition requires specific precautions. Both medications carry similar contraindications - personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, and previous serious hypersensitivity to GLP-1 receptor agonists. If you developed any serious adverse reactions to Wegovy, our prescribers will carefully evaluate whether Mounjaro is appropriate[2].

The risk of hypoglycaemia increases if you're taking Mounjaro alongside other glucose-lowering medications, particularly insulin or sulphonylureas. During your Wegovy to Mounjaro switch assessment, inform our prescribers about all diabetes medications you're using. Dose adjustments to these concurrent therapies may be necessary to prevent low blood sugar episodes. Our clinical team provides specific guidance on blood glucose monitoring frequency during the transition period for patients with type 2 diabetes.

Gastrointestinal side effects represent the most common safety concern during the switch period. Whilst most patients tolerate the transition well, severe or persistent nausea, vomiting, or diarrhoea warrant clinical review. Our pharmacists are available to provide management strategies, but severe symptoms - particularly those causing dehydration or inability to tolerate oral intake - require medical assessment. We provide clear guidance on when to contact our clinical team versus when to seek urgent medical care during your Wegovy to Mounjaro switch journey.

Medication Interactions to Consider

Tirzepatide's effect on gastric emptying can alter the absorption of oral medications, similar to semaglutide's mechanism. If you take medications with narrow therapeutic windows - such as levothyroxine, warfarin, or certain antibiotics - inform our prescribers during your Wegovy to Mounjaro switch assessment. Timing adjustments or additional monitoring may be recommended to maintain therapeutic efficacy of these concurrent medications. Our pharmaceutical team provides personalised guidance on optimal medication scheduling to minimise interaction risks.

Scientific References

  1. Frías, J. P., Davies, M. J., Rosenstock, J., Pérez Manghi, F. C., Fernández Landó, L., Bergman, B. K., ... & SURPASS-2 Investigators. (2021). Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes. New England Journal of Medicine, 385(6), 503-515. [accessed 15 August 2026]
  2. Nauck, M. A., Quast, D. R., Wefers, J., & Meier, J. J. (2021). GLP-1 receptor agonists in the treatment of type 2 diabetes – state-of-the-art. Molecular Metabolism, 46, 101102. [accessed 15 August 2026]
  3. Lau, J., Bloch, P., Schäffer, L., Pettersson, I., Spetzler, J., Kofoed, J., ... & Feigh, M. (2015). Discovery of the once-weekly glucagon-like peptide-1 (GLP-1) analogue semaglutide. Journal of Medicinal Chemistry, 58(7), 7370-7380. [accessed 15 August 2026]
  4. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., Wharton, S., Connery, L., Alves, B., ... & SURMOUNT-1 Investigators. (2022). Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 387(3), 205-216. [accessed 15 August 2026]
  5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 15 August 2026.
  6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 15 August 2026.
  7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 15 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.

Trusted by thousands

Real people, real results

Jane L.

"Brilliant. Lost 4 stone on mounjaro no side effects at all. Cured pharmacy are excellent. Always helpful pens sent out quickly always comes with needles and sterile wipes. If you want to go on GLP-1 go to cured pharmacy. So professional. Thank you cured pharmacy you changed my health and well being."

Ann-Marie

"I absolutely love this product, I have been using 2.5mg as maintenance dose and have managed to control my weight without any side effects and can still eat well balanced meals. The pharmacy is very efficient friendly and helpful I would not purchase from anywhere else."

Sacha W.

"So far I'm really impressed by my results it's crazy cause I'm not snacking like how I used to do and I see my face slimming down already and it's only been 2 and a half weeks. Can't wait to give my feedback in 5 months time thank you cured pharmacy."

Kimberly G.

"Mounjaro has corrected my hormonal weight gain during menopause. I am using it now to maintain that balance. The results for me have been exceptional!"

Jennifer

"Great really helps cure those nasty habits can't wait for my next mounjaro pen."

How it Works?

Select from our recommended UK-licensed medications.

1

Choose your treatment

Step 1: Choose your treatment from Cured Pharmacy

Select safe UK treatments. Quick answers.

2

Answer quick questions

Step 2: Answer quick consultation questions

We will deliver direct to you as quickly as tomorrow.

3

Get it delivered fast

Step 3: Fast discreet delivery to your door

Start Your Assessment For Weight Loss

Start your journey to better health today.

  • Reviewed by UK-based prescribers
  • Takes under 3 minutes
  • Discreet Packaging

Start Your Journey To Better Health Today

Once you complete a short online assessment you will be able to choose your preferred treatment from safe medically approved options tailored to you.

Start My Assessment

Returning Customer?

Log in to Your Account

Faq

How long should I wait between my last Wegovy dose and first Mounjaro injection when making the switch?
Our prescribers typically recommend waiting one week between your final Wegovy injection and first Mounjaro dose. This timing maintains therapeutic GLP-1 receptor activity whilst minimising overlapping drug exposure during your Wegovy to Mounjaro switch.
Will I need to start Mounjaro at the lowest dose even if I was on Wegovy 1.7mg or higher?
Yes, all patients switching from Wegovy to Mounjaro begin with the 2.5mg tirzepatide initiation dose regardless of their previous semaglutide dose. This graduated approach reduces side effect risk whilst allowing adaptation to tirzepatide's dual-agonist mechanism.
Can I switch from Wegovy to Mounjaro if I experienced side effects on semaglutide?
Mild to moderate gastrointestinal side effects on Wegovy don't preclude switching to Mounjaro, though our prescribers evaluate each case individually. Some patients tolerate tirzepatide better due to its different receptor activity profile, but severe reactions to Wegovy require careful clinical assessment before switching.
How much weight loss can I expect after switching from Wegovy to Mounjaro?
Weight loss outcomes following a Wegovy to Mounjaro switch vary by individual, but clinical trials show tirzepatide produces superior results compared to semaglutide. Expect continued gradual weight reduction rather than the rapid initial losses seen in treatment-naïve patients, with maximum benefit typically achieved over 9-12 months.
Does Cured Pharmacy require a new prescription for my Wegovy to Mounjaro switch?
Yes, switching from Wegovy to Mounjaro requires a new prescription from a UK-registered prescriber. Our online assessment captures your complete Wegovy treatment history, allowing our clinical team to make informed prescribing decisions for your switch to tirzepatide.
Will my side effects from Wegovy continue when I switch to Mounjaro?
Side effect profiles vary during the Wegovy to Mounjaro switch period. Some patients report reduced gastrointestinal symptoms with tirzepatide, whilst others experience similar effects during the first 4-6 weeks. Most side effects resolve as your body adapts to Mounjaro's dual-agonist mechanism.
Can I switch back to Wegovy if Mounjaro doesn't suit me?
Yes, patients can switch back to Wegovy if Mounjaro proves unsuitable, subject to prescriber approval. Our clinical team evaluates the reasons for wanting to return to semaglutide and ensures any switch is clinically appropriate for your individual circumstances.
Is the Wegovy to Mounjaro switch covered by the NHS?
NHS availability of both Wegovy and Mounjaro remains limited, with strict eligibility criteria and significant regional variation in access. Most patients switching from Wegovy to Mounjaro fund treatment privately through registered UK pharmacies like Cured Pharmacy, where transparent pricing and clinical support are provided.
Tarun Kumar, Prescribing Pharmacist

Medically reviewed by

Tarun Kumar, Prescribing Pharmacist (GPhC 2233073)

Reviewed on: June 03, 2026

Last reviewed: 15 August 2026

Last updated on 15 August 2026.

Review History

Our experts continually monitor new findings in health and medicine, and we update our articles when new information becomes available.

Why this page was updated on 15 August 2026

Content checked and updated as part of our periodic review, to ensure accuracy and currentness.

Current version (15 August 2026)

Edited by: The Editorial Team

Medically reviewed by:

Tarun Kumar, GPhC No. 2233073, Prescribing Pharmacist


How we source info.

When we present you with stats, data, opinion or a consensus, we'll tell you where this came from.